Schonfeld Strategic Advisors LLC

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1665241 NEW YORK, NY

Back to AMRX Full portfolio

Position in AMRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,296,704

+$4,839,256 QoQ

Shares Held

305,991

+731.5% QoQ

Ownership

0.096%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#69

of 305 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $64,099,635 across 21 Drug Manufacturers - Specialty & Generic names. AMRX ranks #5 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HROW	Harrow, Inc.	319,625	$13,574,473
2	ALKS	Alkermes plc.	195,174	$10,227,117
3	BCRX	Biocryst Pharmaceuticals Inc	710,816	$7,108,160
4	INDV	Indivior Pharmaceuticals, Inc.	130,982	$5,374,191
5	AMRX	Amneal Pharmaceuticals, Inc. This page	305,991	$5,296,704
6	ZTS	Zoetis Inc.	63,752	$4,581,218
7	ANIP	Ani Pharmaceuticals Inc	41,217	$3,411,943
8	HLN	Haleon plc	363,872	$3,394,925

All Filings in AMRX

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,296,704	305,991	+731.5%	Shares	Sole	2026-08-14
2026-03-31	$457,448	36,802	-31.6%	Shares	Sole	2026-05-15
2025-06-30	$435,007	53,771	+316.8%	Shares	Sole	2025-08-14
2025-03-31	$108,102	12,900	-45.6%	Shares	Sole	2025-05-15
2023-06-30	$73,470	23,700	-1.2%	Shares	Sole	2023-08-14
2023-03-31	$33,360	24,000	-17.0%	Shares	Sole	2023-05-15
2022-12-31	$57,511	28,900	-10.7%	Shares	Sole	2023-02-14
2022-09-30	$65,351	32,352	-47.5%	Shares	Sole	2022-11-14
2021-03-31	$414,345	61,567	+78.5%	Shares	Sole	2021-05-17
2020-12-31	$157,665	34,500	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.